Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 738

1.

Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders.

Chhetri JK, Chan P, Vellas B, Touchon J, Gauthier S.

J Prev Alzheimers Dis. 2019;6(2):144-147. doi: 10.14283/jpad.2019.2.

PMID:
30756122
2.

Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR Jr, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS.

Brain. 2019 Feb 11. doi: 10.1093/brain/awz019. [Epub ahead of print]

PMID:
30753379
3.

Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Guillo Benarous F, Ulysse A, Oo T, Vedvyas A, Rao JA, Marsh K, Kluger A, Sangha J, Hassan M, Alshalabi M, Arain F, Shaikh N, Buj M, Kenowsky S, Masurkar AV, Rabin L, Noroozian M, Sánchez-Saudinós MAB, Blesa R, Auer S, Zhang Y, de Leon M, Sadowski M, Wisniewski T, Gauthier S, Shao Y.

J Alzheimers Dis. 2019;67(2):685-705. doi: 10.3233/JAD-180341.

PMID:
30689585
4.

Openness, inclusion, and respect in dementia research.

Thorogood A, Mäki-Petäjä-Leinonen A, Dalpé G, Gastmans C, Gauthier S.

Lancet Neurol. 2019 Feb;18(2):135-136. doi: 10.1016/S1474-4422(18)30445-9. No abstract available.

PMID:
30663603
5.

IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.

Gauthier SD, Moutuou MM, Daudelin F, Leboeuf D, Guimond M.

Biol Blood Marrow Transplant. 2018 Dec 19. pii: S1083-8791(18)30888-7. doi: 10.1016/j.bbmt.2018.12.066. [Epub ahead of print]

PMID:
30576835
6.

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA.

Brain. 2019 Jan 1;142(1):133-145. doi: 10.1093/brain/awy296.

PMID:
30561514
7.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2018 Nov 9. doi: 10.1007/s12035-018-1405-1. [Epub ahead of print]

PMID:
30414086
8.

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.

Zhang H, Ng KP, Therriault J, Kang MS, Pascoal TA, Rosa-Neto P, Gauthier S; Alzheimer’s Disease Neuroimaging Initiative.

Transl Neurodegener. 2018 Sep 10;7:23. doi: 10.1186/s40035-018-0127-7. eCollection 2018.

9.

Consent recommendations for research and international data sharing involving persons with dementia.

Thorogood A, Mäki-Petäjä-Leinonen A, Brodaty H, Dalpé G, Gastmans C, Gauthier S, Gove D, Harding R, Knoppers BM, Rossor M, Bobrow M; Global Alliance for Genomics and Health, Ageing and Dementia Task Team.

Alzheimers Dement. 2018 Oct;14(10):1334-1343. doi: 10.1016/j.jalz.2018.05.011. Epub 2018 Jul 2.

10.

The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia.

Ng KP, Chiew HJ, Lim L, Rosa-Neto P, Kandiah N, Gauthier S.

Expert Rev Neurother. 2018 Nov;18(11):859-869. doi: 10.1080/14737175.2018.1532792. Epub 2018 Oct 10.

PMID:
30286681
11.

Resident and attending perceptions of direct observation in internal medicine: a qualitative study.

Gauthier S, Melvin L, Mylopoulos M, Abdullah N.

Med Educ. 2018 Dec;52(12):1249-1258. doi: 10.1111/medu.13680. Epub 2018 Oct 1.

PMID:
30276856
12.

Interpersonal Synchronization, Motor Coordination, and Control Are Impaired During a Dynamic Imitation Task in Children With Autism Spectrum Disorder.

Xavier J, Gauthier S, Cohen D, Zahoui M, Chetouani M, Villa F, Berthoz A, Anzalone S.

Front Psychol. 2018 Sep 3;9:1467. doi: 10.3389/fpsyg.2018.01467. eCollection 2018.

13.

Surface manipulation of a curved polycyclic aromatic hydrocarbon-based nano-vehicle molecule equipped with triptycene wheels.

Soe WH, Durand C, Guillermet O, Gauthier S, de Rouville HJ, Srivastava S, Kammerer C, Rapenne G, Joachim C.

Nanotechnology. 2018 Dec 7;29(49):495401. doi: 10.1088/1361-6528/aae0d9. Epub 2018 Sep 12.

PMID:
30207539
14.

Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea.

Gagnon K, Baril AA, Montplaisir J, Carrier J, Chami S, Gauthier S, Lafond C, Gagnon JF, Gosselin N.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801137. doi: 10.1183/13993003.01137-2018. Print 2018 Nov.

PMID:
30190270
15.

Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

Kaur G, Gauthier SA, Perez-Gonzalez R, Pawlik M, Singh AB, Cosby B, Mohan PS, Smiley JF, Levy E.

Neurobiol Dis. 2018 Dec;120:165-173. doi: 10.1016/j.nbd.2018.08.025. Epub 2018 Sep 1.

PMID:
30176349
16.

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.

Zhang H, Therriault J, Kang MS, Ng KP, Pascoal TA, Rosa-Neto P, Gauthier S; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2018 Aug 16;10(1):80. doi: 10.1186/s13195-018-0407-6.

17.

Does time since fire drive live aboveground biomass and stand structure in low fire activity boreal forests? Impacts on their management.

Portier J, Gauthier S, Cyr G, Bergeron Y.

J Environ Manage. 2018 Nov 1;225:346-355. doi: 10.1016/j.jenvman.2018.07.100. Epub 2018 Aug 6.

18.

Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.

Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.

PLoS One. 2018 Aug 9;13(8):e0201289. doi: 10.1371/journal.pone.0201289. eCollection 2018.

19.

Optimal use of cholinergic drugs in Alzheimer's disease.

Gauthier S, Herrmann N, Rosa-Neto P.

Brain. 2018 Sep 1;141(9):e68. doi: 10.1093/brain/awy204. No abstract available.

PMID:
30084978
20.

In vivo quantification of neurofibrillary tangles with [18F]MK-6240.

Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, Bennacef I, Therriault J, Ng KP, Hopewell R, Bouhachi R, Hsiao HH, Benedet AL, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P.

Alzheimers Res Ther. 2018 Jul 31;10(1):74. doi: 10.1186/s13195-018-0402-y.

21.

Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.

Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA.

Neuroimage Clin. 2018 May 8;19:417-424. doi: 10.1016/j.nicl.2018.05.003. eCollection 2018.

22.

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial.

Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Shi L, Gong M, Xu H, Li F, He J, Song H, Yang S, Zhou A, Wang F, Zuo X, Chu C, Liang J, Jia L, Gauthier S.

Alzheimers Dement (N Y). 2018 Mar 22;4:108-117. doi: 10.1016/j.trci.2018.02.004. eCollection 2018.

23.

Expert Consensus on Clinical Diagnostic Criteria for Fatal Familial Insomnia.

Wu LY, Zhan SQ, Huang ZY, Zhang B, Wang T, Liu CF, Lu H, Dong XP, Wu ZY, Zhang JW, Zhang JH, Zhao ZX, Han F, Huang Y, Lu J, Gauthier S, Jia JP, Wang YP.

Chin Med J (Engl). 2018 Jul 5;131(13):1613-1617. doi: 10.4103/0366-6999.235115. No abstract available.

24.

Behavioral Own-Body-Transformations in Children and Adolescents With Typical Development, Autism Spectrum Disorder, and Developmental Coordination Disorder.

Gauthier S, Anzalone SM, Cohen D, Zaoui M, Chetouani M, Villa F, Berthoz A, Xavier J.

Front Psychol. 2018 May 25;9:676. doi: 10.3389/fpsyg.2018.00676. eCollection 2018.

25.

Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

Gauthier S, Zhang H, Ng KP, Pascoal TA, Rosa-Neto P.

Transl Neurodegener. 2018 May 31;7:12. doi: 10.1186/s40035-018-0117-9. eCollection 2018. Review.

26.

New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS.

Alzheimers Dement. 2018 Jun;14(6):703-706. doi: 10.1016/j.jalz.2018.05.002. Epub 2018 May 26. No abstract available.

PMID:
29842864
27.

Influence of Cu adatoms on the molecular assembly of 4,4'-bipyridine on Cu(111).

Dubois MA, Guillermet O, Gauthier S, Zhan G, Makoudi Y, Palmino F, Bouju X, Rochefort A.

Phys Chem Chem Phys. 2018 Jun 6;20(22):15350-15357. doi: 10.1039/c8cp01184b.

PMID:
29796573
28.

Individual variation, population-specific behaviours and stochastic processes shape marine migration phenologies.

Freshwater C, Trudel M, Beacham TD, Gauthier S, Johnson SC, Neville CE, Juanes F.

J Anim Ecol. 2019 Jan;88(1):67-78. doi: 10.1111/1365-2656.12852. Epub 2018 Jun 12.

PMID:
29790171
29.

Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.

Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J, Sullivan JM, Pryor KO, Hesterman J, Kothari PJ, Vallabhajosula S.

J Neuroimaging. 2018 Sep;28(5):496-505. doi: 10.1111/jon.12519. Epub 2018 May 4.

30.

Acute prediction of outcome and cognitive-communication impairments following traumatic brain injury: The influence of age, education and site of lesion.

Gauthier S, LeBlanc J, Seresova A, Laberge-Poirier A, A Correa J, Alturki AY, Marcoux J, Maleki M, Feyz M, de Guise E.

J Commun Disord. 2018 May - Jun;73:77-90. doi: 10.1016/j.jcomdis.2018.04.003. Epub 2018 Apr 14.

PMID:
29709658
31.

Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.

Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.

J Neurol. 2018 May;265(5):1226-1229. doi: 10.1007/s00415-018-8845-4. Epub 2018 Apr 17.

PMID:
29666985
32.

Current and projected cumulative impacts of fire, drought, and insects on timber volumes across Canada.

Boucher D, Boulanger Y, Aubin I, Bernier PY, Beaudoin A, Guindon L, Gauthier S.

Ecol Appl. 2018 Jul;28(5):1245-1259. doi: 10.1002/eap.1724. Epub 2018 Jun 5.

PMID:
29645330
33.

Fast and Robust Unsupervised Identification of MS Lesion Change Using the Statistical Detection of Changes Algorithm.

Nguyen TD, Zhang S, Gupta A, Zhao Y, Gauthier SA, Wang Y.

AJNR Am J Neuroradiol. 2018 May;39(5):830-833. doi: 10.3174/ajnr.A5594. Epub 2018 Mar 8.

34.

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Deh K, Ponath GD, Molvi Z, Parel GT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A, Gauthier SA, Pitt D, Wang Y.

J Magn Reson Imaging. 2018 Nov;48(5):1281-1287. doi: 10.1002/jmri.25997. Epub 2018 Mar 8.

PMID:
29517817
35.

Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.

Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P.

J Alzheimers Dis. 2018;64(s1):S23-S31. doi: 10.3233/JAD-179924.

36.

Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.

Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J; Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group.

JAMA Neurol. 2018 May 1;75(5):608-619. doi: 10.1001/jamaneurol.2017.5135.

PMID:
29482212
37.

Corrigendum to "Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation"[NeuroImage 129 (2016) 1-14].

Schoemaker D, Buss C, Head K, Sandman CA, Davis EP, Chakravarty MM, Gauthier S, Pruessner JC.

Neuroimage. 2018 Jun;173:1-2. doi: 10.1016/j.neuroimage.2018.02.009. Epub 2018 Feb 21. No abstract available.

PMID:
29477029
38.

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurol Genet. 2018 Jan 30;4(1):e216. doi: 10.1212/NXG.0000000000000216. eCollection 2018 Feb.

39.

Push-pull D-π-Ru-π-A chromophores: synthesis and electrochemical, photophysical and second-order nonlinear optical properties.

Durand RJ, Gauthier S, Achelle S, Groizard T, Kahlal S, Saillard JY, Barsella A, Le Poul N, Le Guen FR.

Dalton Trans. 2018 Mar 12;47(11):3965-3975. doi: 10.1039/c8dt00093j.

PMID:
29464264
40.

Dementia clinical trial implications of mild behavioral impairment.

Mortby ME, Black SE, Gauthier S, Miller D, Porsteinsson A, Smith EE, Ismail Z.

Int Psychogeriatr. 2018 Feb;30(2):171-175. doi: 10.1017/S1041610218000042.

PMID:
29448970
41.

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.

Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2018 Mar 13;90(11):e932-e939. doi: 10.1212/WNL.0000000000005120. Epub 2018 Feb 14.

42.

The cost of Alzheimer's disease in China and re-estimation of costs worldwide.

Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han Y, Han Y, Huang L, Wang Q, Li D, Chu C, Shi L, Gong M, Du Y, Zhang J, Zhang J, Zhou C, Lv J, Lv Y, Xie H, Ji Y, Li F, Yu E, Luo B, Wang Y, Yang S, Qu Q, Guo Q, Liang F, Zhang J, Tan L, Shen L, Zhang K, Zhang J, Peng D, Tang M, Lv P, Fang B, Chu L, Jia L, Gauthier S.

Alzheimers Dement. 2018 Apr;14(4):483-491. doi: 10.1016/j.jalz.2017.12.006. Epub 2018 Feb 9.

PMID:
29433981
43.

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.

Pascoal TA, Mathotaarachchi S, Shin M, Park AY, Mohades S, Benedet AL, Kang MS, Massarweh G, Soucy JP, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1021-1030. doi: 10.1007/s00259-018-3933-3. Epub 2018 Feb 2.

44.

Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions.

Zhang S, Nguyen TD, Zhao Y, Gauthier SA, Wang Y, Gupta A.

Neuroimage Clin. 2018 Jan 28;18:143-148. doi: 10.1016/j.nicl.2018.01.013. eCollection 2018.

45.

Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Chiang GC, Hu J, Morris E, Wang Y, Gauthier SA.

AJNR Am J Neuroradiol. 2018 Jan 25. doi: 10.3174/ajnr.A5537. [Epub ahead of print]

PMID:
29371258
46.

MEMO+: Efficacy, Durability and Effect of Cognitive Training and Psychosocial Intervention in Individuals with Mild Cognitive Impairment.

Belleville S, Hudon C, Bier N, Brodeur C, Gilbert B, Grenier S, Ouellet MC, Viscogliosi C, Gauthier S.

J Am Geriatr Soc. 2018 Apr;66(4):655-663. doi: 10.1111/jgs.15192. Epub 2018 Jan 4.

PMID:
29313875
47.

Impacts of salvage logging on biodiversity: a meta-analysis.

Thorn S, Bässler C, Brandl R, Burton PJ, Cahall R, Campbell JL, Castro J, Choi CY, Cobb T, Donato DC, Durska E, Fontaine JB, Gauthier S, Hebert C, Hothorn T, Hutto RL, Lee EJ, Leverkus AB, Lindenmayer DB, Obrist MK, Rost J, Seibold S, Seidl R, Thom D, Waldron K, Wermelinger B, Winter MB, Zmihorski M, Müller J.

J Appl Ecol. 2018 Jan;55(1):279-289. doi: 10.1111/1365-2664.12945. Epub 2017 Jul 5.

48.

Comparative effect of statins on the risk of incident Alzheimer disease.

Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P.

Neurology. 2018 Jan 16;90(3):e179-e187. doi: 10.1212/WNL.0000000000004818. Epub 2017 Dec 15.

PMID:
29247073
49.

Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.

Yao Y, Nguyen TD, Pandya S, Zhang Y, Hurtado Rúa S, Kovanlikaya I, Kuceyeski A, Liu Z, Wang Y, Gauthier SA.

AJNR Am J Neuroradiol. 2018 Feb;39(2):303-310. doi: 10.3174/ajnr.A5482. Epub 2017 Dec 14.

50.

EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.

Aisen P, Touchon J, Amariglio R, Andrieu S, Bateman R, Breitner J, Donohue M, Dunn B, Doody R, Fox N, Gauthier S, Grundman M, Hendrix S, Ho C, Isaac M, Raman R, Rosenberg P, Schindler R, Schneider L, Sperling R, Tariot P, Welsh-Bohmer K, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2017;4(2):116-124. doi: 10.14283/jpad.2017.13.

Supplemental Content

Loading ...
Support Center